Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Single-Use Wipes Are Making Germs Stronger, with John Shanahan of Ionogen

Did you know that the leading blue glass cleaner can kill you? Were you aware that the single-use wipes that many of us have in our kitchens and bathrooms are also putting our health at risk? At least, that’s what our guest today claims after years of research and industry experience. John Shanahan, President…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Did you know that the leading blue glass cleaner can kill you? Were you aware that the single-use wipes that many of us have in our kitchens and bathrooms are also putting our health at risk? At least, that’s what our guest today claims after years of research and industry experience.

John Shanahan, President & CEO of Ionogen, was recently at a social function and was questioned by another guest who heard his latest podcast appearance and begged to differ that the products were harmful. After Shanahan read the ingredient list and then asked again if she would use the product around her four-year-old granddaughter, she had a very different take on the safety of the products.

Why aren’t more Americans reading labels and what does a more practical sanitation solution look like? Shanahan’s research has pointed to single-use wipes potentially causing cancer, and yet most people aren’t aware of this because there aren’t many options to choose from. There isn’t a lot of new chemistry from product to product. Looking at the legacy brands (with 100+ years of retailing), they all use quaternary ammonium as a major ingredient, which can be extremely harmful to humans.

The second problem is that these wipes are often misused. Wiping the toilet seat or bathroom counter is “like a snow plow in Chicago in January,” Shanahan said. “It just starts pushing the germs.”

On this podcast, Shanahan explains how Americans are misusing both consumer-grade and commercial-level single-use wipes, why this is especially problematic for hospitals, and what the alternatives are.

For the latest news, videos, and podcasts in the Building Management Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @BuildingMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512